Scarica l'app Stockscreener
3.69
3.40%
-0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Achieve Life Sciences, Inc. (NASDAQ:ACHV) down to US$131m market cap, but institutional owners may not be as affected after a year of 0.5% returns - Simply Wall St
Franklin Resources Inc. Sells 2,181,025 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat
Charles Schwab Investment Management Inc. Sells 6,324 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Playing the Long Game To Achieve Financial Success - Yahoo Finance
Molecule AI wins award at BioSpectrum Asia Excellence Awards 2024 - European Pharmaceutical Manufacturer
Puerto Rico air cargo community scoops CEIV Pharma certification - Air Cargo News
Axtria Leads Frost & Sullivan's First Pharmaceutical Commercialization Solutions and Services Industry Radar Report - PR Newswire
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Toshinori Agatsuma, Daiichi’s head of research, passes away - BioCentury
Achieve Life Sciences names new CFO By Investing.com - Investing.com Nigeria
Achieve Life Sciences names new CFO - Investing.com India
Achieve Life Sciences Appoints Mark K. Oki as CFO - TipRanks
GFO-X Announces ABN AMRO Clearing, IMC, Standard Chartered Bank and Virtu Financial as Strategic Partners Ahead of Launch in Q1 2025 - The Manila Times
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer - GlobeNewswire
Achieve Life Sciences, Inc. Appoints Mark Oki as Chief Financial Officer - Marketscreener.com
Achieve Life Sciences Taps Biotech Veteran Mark Oki as New CFO to Lead Financial Strategy - StockTitan
Achieve Life Sciences shares rise on positive FDA meeting outcome By Investing.com - Investing.com Canada
Gene Therapy Market Trends in Market Growth: Size, Demand, - openPR
Kane Biotech Announces $3,000,000 Private Placement Offering - The Manila Times
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA - GlobeNewswire
Achieve Life Sciences Gets FDA Green Light for Landmark Vaping Cessation Drug Trial | ACHV Stock News - StockTitan
Smoking Cessation and Nicotine Addiction Market Growth Anticipated by 2034 | Axsome Therapeutics, Achieve Life Sciences, NFL Biosciences SAS, expected to boost the market - The Globe and Mail
Smoking Cessation and Nicotine Addiction Market Growth - openPR
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Down 9.6% in November - MarketBeat
Vaping risks: Study reveals new health concerns - WBBJ-TV
Gene Therapy Market Size, Share, Trends, and Analysis 2024-2032 - openPR
Science Says 3 Strategies Will Help You Achieve Your Big Goals and Live Your Best Life - Inc.
Drug Discovery Outsourcing Services Market to Achieve a Superb - openPR
Clovertex Awarded AWS Life Sciences Competency, Solidifying Leadership in Cloud-Based Solutions for Life Sciences - IT News Online
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives $14.80 Average Price Target from Analysts - Defense World
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Achieve Life Sciences (NASDAQ:ACHV) Raised to “Strong-Buy” at RODMAN&RENSHAW - Defense World
FitLife Brands, Inc. Announces Financial Results for Quarter Ended September 30, 2024 - Defense World
Brokerages Set Achieve Life Sciences, Inc. (NASDAQ:ACHV) Target Price at $14.80 - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Upgraded by RODMAN&RENSHAW to "Strong-Buy" Rating - MarketBeat
Achieve Life Sciences stock rated Buy ahead of NDA submission By Investing.com - Investing.com UK
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire
Achieve Life Sciences to Present at Jefferies, Piper Sandler Healthcare Conferences | ACHV Stock News - StockTitan
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Rodman & Renshaw Begins Coverage on Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
FY2024 Earnings Estimate for ACHV Issued By Zacks Small Cap - Defense World
Research Analysts Set Expectations for ACHV FY2024 Earnings - MarketBeat
How to achieve a successful drug launch in the first year - MM+M Online
ACHV: Commercialization in Focus - Zacks Small Cap Research
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript - Insider Monkey
How to Take Advantage of moves in (ACHV) - Stock Traders Daily
Achieve qtrly loss per share $0.90 - Reuters
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Achieve Life Sciences Reports Q3 2024 Progress - TipRanks
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update - The Manila Times
Parallel Fluidics Secures $7M Seed Round to Accelerate Microfluidic Development for the Next Generation of Life Science Tools - IT News Online
Modular Data Center Market worth $79.49 billion by 2030- Exclusive Report by MarketsandMarkets - The Malaysian Reserve
Vanguard Group Inc's Strategic Acquisition in Achieve Life Scien - GuruFocus.com
JonesTrading Initiates Coverage of Achieve Life Sciences (ACHV) with Buy Recommendation - MSN
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):